Clinical observation of Ningkun Jieyu Decoction on perimenopausal syndrome and its effect on serum metabonomics
- Conditions
- Perimenopausal syndrome
- Registration Number
- ITMCTR2100004824
- Lead Sponsor
- Xiyuan Hospital of China Academy for TCM
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- Not specified
1.The female met the above diagnostic criteria of traditional Chinese and Western medicine, the age was more than 50 years old, and the modified Kupperman scale score was less than or equal to 30;
2.Those who have not taken estrogen or have taken them but have stopped for more than 1 month;
3.The patients with good compliance can take medicine for 2 months according to the doctor's advice;
4.Those who voluntarily agree to participate in the study and sign the informed consent form.
1.Patients with bilateral ovariectomy, ovarian tumor or premature ovarian failure;
2.Patients with allergic constitution or allergic history of traditional Chinese medicine;
3.Patients with serious primary diseases such as cardiovascular, cerebrovascular, liver, kidney or hematopoietic system or patients with mental diseases;
4.The patients who could not judge the efficacy, or the information was incomplete, which affected the efficacy or safety judgment.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.